Nirogacestat - A New Treatment For Desmoid Tumors

Nirogacestat - A new treatment for Desmoid Tumors

Therapeutic Window

Nirogacestat emerges as a treatment for desmoid tumor: 2022 ESMO Florida

Total Health | Oncology

New medical therapies in Desmoid Tumor: Nirogacestat - Palassini, MD

Desmoid Foundation

Treatment Options for Desmoid Tumors, Including Nirogacestat in Children

Nirogacestat’s Mechanism of Action to Treat Desmoid Tumors

Desmoid Tumors: Phase 3 Clinical Trial Data With Nirogacestat Shows Promise

#ESMO22 Highlights on nirogacestat in patients with progressing desmoid tumours: The DeFi study

European Society for Medical Oncology (ESMO)

Nirogacestat Being Evaluated for Desmoid Tumors in Adults and Children

DeFi trial: nirogacestat vs placebo for patients with progressing desmoid tumors

Nirogacestat success for desmoid tumours

Past, Present, and Future Treatment Options for Desmoid Tumors

DeFi: nirogacestat demonstrates improved PFS and ORR in progressing desmoid tumors

Nirogacestat improves outcomes for people with sarcoma, shows phase 3 clinical trial

Medical Dialogues

Understanding Cryoablation for Desmoid Tumor

Stanford Health Care

Modernizing the Treatment of Desmoid Tumors With Novel Gamma Secretase Inhibitors

PeerView Oncology

Nirogacestat For Desmoid Tumors, Pirtobrutinib for CLL/SLL, Enfortumab Vedotin With...

Nascent Medical

Maine woman diagnosed with desmoid tumor raising awareness, money for research

Future perspectives in the treatment of Desmoid Tumor - Stacchiotti, MD

Desmoid Foundation

Knowledge Spot Webinar: Gamma Secretase Inhibitors - A new paradigm in Desmoid Tumors?

Sarcoma Patient Advocacy Global Network SPAGN

FDA Approves Ogsiveo (nirogacestat) for Adults with Desmoid Tumors...